Lymph node status in inflammatory breast cancer.

Item

http://www.wikidata.org/entity/Q41110592

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Lymph node status in inflammatory breast cancer.

@en

type

Item

label

Lymph node status in inflammatory breast cancer.

@en

prefLabel

Lymph node status in inflammatory breast cancer.

@en

P1476

Lymph node status in inflammatory breast cancer

@en

P2093

Christy A Russell

http://www.w3.org/2001/XMLSchema#string

Haiyan Cui

http://www.w3.org/2001/XMLSchema#string

Julie E Lang

http://www.w3.org/2001/XMLSchema#string

Julie S Wecsler

http://www.w3.org/2001/XMLSchema#string

Michelle R Sieffert

http://www.w3.org/2001/XMLSchema#string

Rebecca K Viscusi

http://www.w3.org/2001/XMLSchema#string

Rose C Pedersen

http://www.w3.org/2001/XMLSchema#string

Ryan R Woods

http://www.w3.org/2001/XMLSchema#string

Stephen F Sener

http://www.w3.org/2001/XMLSchema#string

Welela Tereffe

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute.

Locoregional treatment outcomes after multimodality management of inflammatory breast cancer

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

Survival of women with inflammatory breast cancer: a large population-based study

Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer

Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry

Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center.

P2888

s10549-015-3367-6

P304

113-120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-015-3367-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

151

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274642290

http://www.w3.org/2001/XMLSchema#string

P6179

1014920131

http://www.w3.org/2001/XMLSchema#string

P698

25846421

http://www.w3.org/2001/XMLSchema#string

P932

7032612

http://www.w3.org/2001/XMLSchema#string